HEADER TRANSCRIPTION 02-JUL-21 7F8G TITLE STRUCTURE-ACTIVITY RELATIONSHIP STUDIES OF ALLOSTERIC INHIBITORS OF TITLE 2 EYA2 TYROSINE PHOSPHATASE COMPND MOL_ID: 1; COMPND 2 MOLECULE: EYES ABSENT HOMOLOG 2; COMPND 3 CHAIN: B, A; COMPND 4 EC: 3.1.3.48; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: EYA2, EAB1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS EYA2, EYES ABSENT PROTEIN, PHOSPHATASE, TRANSCRIPTION COACTIVATOR, KEYWDS 2 TRANSCRIPTION EXPDTA X-RAY DIFFRACTION AUTHOR J.ANANTHARAJAN,N.BABURAJENDRAN REVDAT 3 29-NOV-23 7F8G 1 REMARK REVDAT 2 23-FEB-22 7F8G 1 JRNL REVDAT 1 29-DEC-21 7F8G 0 JRNL AUTH J.ANANTHARAJAN,N.BABURAJENDRAN,G.LIN,Y.Y.LOH,W.XU, JRNL AUTH 2 N.H.B.AHMAD,S.LIU,A.E.JANSSON,J.W.L.KUAN,E.Y.NG,Y.K.YEO, JRNL AUTH 3 A.W.HUNG,J.JOY,J.HILL,H.L.FORD,R.ZHAO,T.H.KELLER,C.KANG JRNL TITL STRUCTURE-ACTIVITY RELATIONSHIP STUDIES OF ALLOSTERIC JRNL TITL 2 INHIBITORS OF EYA2 TYROSINE PHOSPHATASE. JRNL REF PROTEIN SCI. V. 31 422 2022 JRNL REFN ESSN 1469-896X JRNL PMID 34761455 JRNL DOI 10.1002/PRO.4234 REMARK 2 REMARK 2 RESOLUTION. 3.49 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.11.1_2575 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.49 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 44.96 REMARK 3 MIN(FOBS/SIGMA_FOBS) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 96.7 REMARK 3 NUMBER OF REFLECTIONS : 10762 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.219 REMARK 3 R VALUE (WORKING SET) : 0.214 REMARK 3 FREE R VALUE : 0.267 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.040 REMARK 3 FREE R VALUE TEST SET COUNT : 1080 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 44.9600 - 6.9740 0.95 1195 123 0.1596 0.2084 REMARK 3 2 6.9740 - 5.5387 0.94 1190 127 0.2296 0.2874 REMARK 3 3 5.5387 - 4.8395 0.96 1193 139 0.2202 0.3149 REMARK 3 4 4.8395 - 4.3974 0.97 1217 141 0.1962 0.2130 REMARK 3 5 4.3974 - 4.0825 0.97 1203 127 0.2206 0.2561 REMARK 3 6 4.0825 - 3.8419 0.98 1246 148 0.2308 0.2841 REMARK 3 7 3.8419 - 3.6496 0.98 1217 134 0.2660 0.3279 REMARK 3 8 3.6496 - 3.4910 0.98 1221 141 0.2862 0.3721 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.430 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 28.320 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 82.22 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 83.32 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.003 4083 REMARK 3 ANGLE : 0.603 5555 REMARK 3 CHIRALITY : 0.043 640 REMARK 3 PLANARITY : 0.003 704 REMARK 3 DIHEDRAL : 2.113 3216 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : 1 REMARK 3 NCS GROUP : 1 REMARK 3 NCS OPERATOR : 1 REMARK 3 REFERENCE SELECTION: (CHAIN A AND (RESID 266 THROUGH 276 OR REMARK 3 (RESID 277 AND (NAME N OR NAME CA OR NAME REMARK 3 C OR NAME O OR NAME CB )) OR RESID 278 REMARK 3 THROUGH 310 OR (RESID 311 AND (NAME N OR REMARK 3 NAME CA OR NAME C OR NAME O OR NAME CB )) REMARK 3 OR RESID 312 THROUGH 321 OR (RESID 322 REMARK 3 AND (NAME N OR NAME CA OR NAME C OR NAME REMARK 3 O OR NAME CB )) OR RESID 323 THROUGH 343 REMARK 3 OR (RESID 344 AND (NAME N OR NAME CA OR REMARK 3 NAME C OR NAME O OR NAME CB )) OR RESID REMARK 3 345 THROUGH 375 OR (RESID 376 AND (NAME N REMARK 3 OR NAME CA OR NAME C OR NAME O OR NAME CB REMARK 3 )) OR RESID 377 THROUGH 439 OR (RESID 440 REMARK 3 AND (NAME N OR NAME CA OR NAME C OR NAME REMARK 3 O OR NAME CB )) OR RESID 441 THROUGH 480 REMARK 3 OR (RESID 481 AND (NAME N OR NAME CA OR REMARK 3 NAME C OR NAME O OR NAME CB )) OR RESID REMARK 3 482 THROUGH 506 OR (RESID 507 THROUGH 508 REMARK 3 AND (NAME N OR NAME CA OR NAME C OR NAME REMARK 3 O OR NAME CB )) OR RESID 509 THROUGH 530 REMARK 3 OR RESID 532 THROUGH 538)) REMARK 3 SELECTION : (CHAIN B AND ((RESID 266 THROUGH 269 AND REMARK 3 (NAME N OR NAME CA OR NAME C OR NAME O OR REMARK 3 NAME CB )) OR RESID 270 THROUGH 280 OR REMARK 3 (RESID 281 AND (NAME N OR NAME CA OR NAME REMARK 3 C OR NAME O OR NAME CB )) OR RESID 282 REMARK 3 THROUGH 292 OR (RESID 293 AND (NAME N OR REMARK 3 NAME CA OR NAME C OR NAME O OR NAME CB )) REMARK 3 OR RESID 294 THROUGH 323 OR RESID 325 REMARK 3 THROUGH 377 OR (RESID 378 THROUGH 379 AND REMARK 3 (NAME N OR NAME CA OR NAME C OR NAME O OR REMARK 3 NAME CB )) OR RESID 380 THROUGH 411 OR REMARK 3 (RESID 412 AND (NAME N OR NAME CA OR NAME REMARK 3 C OR NAME O OR NAME CB )) OR RESID 413 REMARK 3 THROUGH 415 OR (RESID 416 AND (NAME N OR REMARK 3 NAME CA OR NAME C OR NAME O OR NAME CB )) REMARK 3 OR RESID 417 THROUGH 445 OR (RESID 446 REMARK 3 AND (NAME N OR NAME CA OR NAME C OR NAME REMARK 3 O OR NAME CB )) OR RESID 447 THROUGH 479 REMARK 3 OR (RESID 480 THROUGH 481 AND (NAME N OR REMARK 3 NAME CA OR NAME C OR NAME O OR NAME CB )) REMARK 3 OR RESID 482 THROUGH 504 OR (RESID 505 REMARK 3 THROUGH 508 AND (NAME N OR NAME CA OR REMARK 3 NAME C OR NAME O OR NAME CB )) OR (RESID REMARK 3 509 THROUGH 512 AND (NAME N OR NAME CA OR REMARK 3 NAME C OR NAME O OR NAME CB )) OR RESID REMARK 3 513 THROUGH 530 OR RESID 532 THROUGH 535 REMARK 3 OR (RESID 536 AND (NAME N OR NAME CA OR REMARK 3 NAME C OR NAME O OR NAME CB )) OR RESID REMARK 3 537 THROUGH 538)) REMARK 3 ATOM PAIRS NUMBER : 2218 REMARK 3 RMSD : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7F8G COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 06-JUL-21. REMARK 100 THE DEPOSITION ID IS D_1300023045. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 29-NOV-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : AUSTRALIAN SYNCHROTRON REMARK 200 BEAMLINE : MX2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.95380 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 10772 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.490 REMARK 200 RESOLUTION RANGE LOW (A) : 77.870 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.7 REMARK 200 DATA REDUNDANCY : 2.000 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.49 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.82 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 5ZMA REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 64.06 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.42 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.02M MGCL2, 0.1M HEPES 7.5, 22% POLY REMARK 280 ACRYLIC ACID SODIUM SALT 5100, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 32.28333 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 64.56667 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY B 245 REMARK 465 PRO B 246 REMARK 465 LEU B 247 REMARK 465 GLY B 248 REMARK 465 SER B 249 REMARK 465 PRO B 250 REMARK 465 GLU B 251 REMARK 465 PHE B 252 REMARK 465 SER B 253 REMARK 465 LYS B 254 REMARK 465 ARG B 255 REMARK 465 SER B 256 REMARK 465 SER B 257 REMARK 465 ASP B 258 REMARK 465 PRO B 259 REMARK 465 SER B 260 REMARK 465 PRO B 261 REMARK 465 ALA B 262 REMARK 465 GLY B 263 REMARK 465 ASP B 264 REMARK 465 SER B 358 REMARK 465 ALA B 359 REMARK 465 PRO B 360 REMARK 465 GLY B 361 REMARK 465 ALA B 362 REMARK 465 ASN B 363 REMARK 465 LEU B 364 REMARK 465 CYS B 365 REMARK 465 LEU B 366 REMARK 465 GLY B 367 REMARK 465 SER B 368 REMARK 465 GLY B 369 REMARK 465 VAL B 370 REMARK 465 HIS B 371 REMARK 465 GLY B 372 REMARK 465 GLY A 245 REMARK 465 PRO A 246 REMARK 465 LEU A 247 REMARK 465 GLY A 248 REMARK 465 SER A 249 REMARK 465 PRO A 250 REMARK 465 GLU A 251 REMARK 465 PHE A 252 REMARK 465 SER A 253 REMARK 465 LYS A 254 REMARK 465 ARG A 255 REMARK 465 SER A 256 REMARK 465 SER A 257 REMARK 465 ASP A 258 REMARK 465 PRO A 259 REMARK 465 SER A 260 REMARK 465 PRO A 261 REMARK 465 ALA A 262 REMARK 465 GLY A 263 REMARK 465 ASP A 264 REMARK 465 ASN A 265 REMARK 465 ASP A 324 REMARK 465 SER A 358 REMARK 465 ALA A 359 REMARK 465 PRO A 360 REMARK 465 GLY A 361 REMARK 465 ALA A 362 REMARK 465 ASN A 363 REMARK 465 LEU A 364 REMARK 465 CYS A 365 REMARK 465 LEU A 366 REMARK 465 GLY A 367 REMARK 465 SER A 368 REMARK 465 GLY A 369 REMARK 465 VAL A 370 REMARK 465 HIS A 371 REMARK 465 GLY A 372 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ILE B 267 CG1 CG2 CD1 REMARK 470 GLU B 268 CG CD OE1 OE2 REMARK 470 GLU B 277 CG CD OE1 OE2 REMARK 470 MET B 311 CG SD CE REMARK 470 PHE B 322 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ASP B 329 CG OD1 OD2 REMARK 470 GLN B 330 CG CD OE1 NE2 REMARK 470 ASN B 341 CG OD1 ND2 REMARK 470 ASP B 344 CG OD1 OD2 REMARK 470 HIS B 356 CG ND1 CD2 CE1 NE2 REMARK 470 SER B 357 OG REMARK 470 VAL B 374 CG1 CG2 REMARK 470 TRP B 376 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 470 TRP B 376 CZ3 CH2 REMARK 470 LYS B 379 CG CD CE NZ REMARK 470 GLU B 389 CG CD OE1 OE2 REMARK 470 ARG B 407 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 408 CG CD OE1 OE2 REMARK 470 ASN B 440 CG OD1 ND2 REMARK 470 LYS B 477 CG CD CE NZ REMARK 470 GLU B 481 CG CD OE1 OE2 REMARK 470 GLU B 485 CG CD OE1 OE2 REMARK 470 ARG B 493 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 494 CG CD CE NZ REMARK 470 GLU B 507 CG CD OE1 OE2 REMARK 470 LYS B 511 CG CD CE NZ REMARK 470 GLU B 527 CG CD OE1 OE2 REMARK 470 GLU A 266 CG CD OE1 OE2 REMARK 470 ILE A 267 CG1 CG2 CD1 REMARK 470 GLU A 268 CG CD OE1 OE2 REMARK 470 ARG A 269 CG CD NE CZ NH1 NH2 REMARK 470 ILE A 281 CG1 CG2 CD1 REMARK 470 ARG A 293 CG CD NE CZ NH1 NH2 REMARK 470 ASP A 329 CG OD1 OD2 REMARK 470 GLN A 330 CG CD OE1 NE2 REMARK 470 ASN A 341 CG OD1 ND2 REMARK 470 HIS A 356 CG ND1 CD2 CE1 NE2 REMARK 470 SER A 357 OG REMARK 470 VAL A 374 CG1 CG2 REMARK 470 ARG A 378 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 379 CG CD CE NZ REMARK 470 GLU A 389 CG CD OE1 OE2 REMARK 470 ARG A 407 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 408 CG CD OE1 OE2 REMARK 470 GLN A 412 CG CD OE1 NE2 REMARK 470 GLU A 416 CG CD OE1 OE2 REMARK 470 VAL A 446 CG1 CG2 REMARK 470 LYS A 477 CG CD CE NZ REMARK 470 LYS A 480 CG CD CE NZ REMARK 470 GLU A 485 CG CD OE1 OE2 REMARK 470 ARG A 493 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 494 CG CD CE NZ REMARK 470 GLU A 505 CG CD OE1 OE2 REMARK 470 GLU A 506 CG CD OE1 OE2 REMARK 470 GLN A 508 CG CD OE1 NE2 REMARK 470 LYS A 511 CG CD CE NZ REMARK 470 LYS A 512 CG CD CE NZ REMARK 470 GLU A 527 CG CD OE1 OE2 REMARK 470 HIS A 531 CG ND1 CD2 CE1 NE2 REMARK 470 GLU A 536 CG CD OE1 OE2 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 ARG B 407 CB REMARK 480 GLU B 408 CB REMARK 480 LYS B 494 CB REMARK 480 ARG A 407 CB REMARK 480 GLU A 408 CB REMARK 480 GLU A 416 CB REMARK 480 LYS A 477 CB REMARK 480 LYS A 480 CB REMARK 480 LYS A 494 CB REMARK 480 HIS A 531 CA CB REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU B 277 -5.40 64.07 REMARK 500 THR B 278 -36.09 -139.22 REMARK 500 ILE B 279 -65.98 -126.52 REMARK 500 HIS B 319 -33.19 -138.33 REMARK 500 ALA B 475 32.95 -84.99 REMARK 500 ILE B 520 21.50 -142.59 REMARK 500 GLU A 277 -5.41 63.78 REMARK 500 THR A 278 -36.61 -138.70 REMARK 500 ILE A 279 -65.65 -125.96 REMARK 500 ILE A 280 -72.62 -67.43 REMARK 500 HIS A 319 -35.31 -137.79 REMARK 500 ALA A 352 73.81 -119.84 REMARK 500 ALA A 475 31.83 -84.14 REMARK 500 ILE A 520 20.08 -140.38 REMARK 500 REMARK 500 REMARK: NULL DBREF 7F8G B 253 538 UNP O00167 EYA2_HUMAN 253 538 DBREF 7F8G A 253 538 UNP O00167 EYA2_HUMAN 253 538 SEQADV 7F8G GLY B 245 UNP O00167 EXPRESSION TAG SEQADV 7F8G PRO B 246 UNP O00167 EXPRESSION TAG SEQADV 7F8G LEU B 247 UNP O00167 EXPRESSION TAG SEQADV 7F8G GLY B 248 UNP O00167 EXPRESSION TAG SEQADV 7F8G SER B 249 UNP O00167 EXPRESSION TAG SEQADV 7F8G PRO B 250 UNP O00167 EXPRESSION TAG SEQADV 7F8G GLU B 251 UNP O00167 EXPRESSION TAG SEQADV 7F8G PHE B 252 UNP O00167 EXPRESSION TAG SEQADV 7F8G GLY A 245 UNP O00167 EXPRESSION TAG SEQADV 7F8G PRO A 246 UNP O00167 EXPRESSION TAG SEQADV 7F8G LEU A 247 UNP O00167 EXPRESSION TAG SEQADV 7F8G GLY A 248 UNP O00167 EXPRESSION TAG SEQADV 7F8G SER A 249 UNP O00167 EXPRESSION TAG SEQADV 7F8G PRO A 250 UNP O00167 EXPRESSION TAG SEQADV 7F8G GLU A 251 UNP O00167 EXPRESSION TAG SEQADV 7F8G PHE A 252 UNP O00167 EXPRESSION TAG SEQRES 1 B 294 GLY PRO LEU GLY SER PRO GLU PHE SER LYS ARG SER SER SEQRES 2 B 294 ASP PRO SER PRO ALA GLY ASP ASN GLU ILE GLU ARG VAL SEQRES 3 B 294 PHE VAL TRP ASP LEU ASP GLU THR ILE ILE ILE PHE HIS SEQRES 4 B 294 SER LEU LEU THR GLY THR PHE ALA SER ARG TYR GLY LYS SEQRES 5 B 294 ASP THR THR THR SER VAL ARG ILE GLY LEU MET MET GLU SEQRES 6 B 294 GLU MET ILE PHE ASN LEU ALA ASP THR HIS LEU PHE PHE SEQRES 7 B 294 ASN ASP LEU GLU ASP CYS ASP GLN ILE HIS VAL ASP ASP SEQRES 8 B 294 VAL SER SER ASP ASP ASN GLY GLN ASP LEU SER THR TYR SEQRES 9 B 294 ASN PHE SER ALA ASP GLY PHE HIS SER SER ALA PRO GLY SEQRES 10 B 294 ALA ASN LEU CYS LEU GLY SER GLY VAL HIS GLY GLY VAL SEQRES 11 B 294 ASP TRP MET ARG LYS LEU ALA PHE ARG TYR ARG ARG VAL SEQRES 12 B 294 LYS GLU MET TYR ASN THR TYR LYS ASN ASN VAL GLY GLY SEQRES 13 B 294 LEU ILE GLY THR PRO LYS ARG GLU THR TRP LEU GLN LEU SEQRES 14 B 294 ARG ALA GLU LEU GLU ALA LEU THR ASP LEU TRP LEU THR SEQRES 15 B 294 HIS SER LEU LYS ALA LEU ASN LEU ILE ASN SER ARG PRO SEQRES 16 B 294 ASN CYS VAL ASN VAL LEU VAL THR THR THR GLN LEU ILE SEQRES 17 B 294 PRO ALA LEU ALA LYS VAL LEU LEU TYR GLY LEU GLY SER SEQRES 18 B 294 VAL PHE PRO ILE GLU ASN ILE TYR SER ALA THR LYS THR SEQRES 19 B 294 GLY LYS GLU SER CYS PHE GLU ARG ILE MET GLN ARG PHE SEQRES 20 B 294 GLY ARG LYS ALA VAL TYR VAL VAL ILE GLY ASP GLY VAL SEQRES 21 B 294 GLU GLU GLU GLN GLY ALA LYS LYS HIS ASN MET PRO PHE SEQRES 22 B 294 TRP ARG ILE SER CYS HIS ALA ASP LEU GLU ALA LEU ARG SEQRES 23 B 294 HIS ALA LEU GLU LEU GLU TYR LEU SEQRES 1 A 294 GLY PRO LEU GLY SER PRO GLU PHE SER LYS ARG SER SER SEQRES 2 A 294 ASP PRO SER PRO ALA GLY ASP ASN GLU ILE GLU ARG VAL SEQRES 3 A 294 PHE VAL TRP ASP LEU ASP GLU THR ILE ILE ILE PHE HIS SEQRES 4 A 294 SER LEU LEU THR GLY THR PHE ALA SER ARG TYR GLY LYS SEQRES 5 A 294 ASP THR THR THR SER VAL ARG ILE GLY LEU MET MET GLU SEQRES 6 A 294 GLU MET ILE PHE ASN LEU ALA ASP THR HIS LEU PHE PHE SEQRES 7 A 294 ASN ASP LEU GLU ASP CYS ASP GLN ILE HIS VAL ASP ASP SEQRES 8 A 294 VAL SER SER ASP ASP ASN GLY GLN ASP LEU SER THR TYR SEQRES 9 A 294 ASN PHE SER ALA ASP GLY PHE HIS SER SER ALA PRO GLY SEQRES 10 A 294 ALA ASN LEU CYS LEU GLY SER GLY VAL HIS GLY GLY VAL SEQRES 11 A 294 ASP TRP MET ARG LYS LEU ALA PHE ARG TYR ARG ARG VAL SEQRES 12 A 294 LYS GLU MET TYR ASN THR TYR LYS ASN ASN VAL GLY GLY SEQRES 13 A 294 LEU ILE GLY THR PRO LYS ARG GLU THR TRP LEU GLN LEU SEQRES 14 A 294 ARG ALA GLU LEU GLU ALA LEU THR ASP LEU TRP LEU THR SEQRES 15 A 294 HIS SER LEU LYS ALA LEU ASN LEU ILE ASN SER ARG PRO SEQRES 16 A 294 ASN CYS VAL ASN VAL LEU VAL THR THR THR GLN LEU ILE SEQRES 17 A 294 PRO ALA LEU ALA LYS VAL LEU LEU TYR GLY LEU GLY SER SEQRES 18 A 294 VAL PHE PRO ILE GLU ASN ILE TYR SER ALA THR LYS THR SEQRES 19 A 294 GLY LYS GLU SER CYS PHE GLU ARG ILE MET GLN ARG PHE SEQRES 20 A 294 GLY ARG LYS ALA VAL TYR VAL VAL ILE GLY ASP GLY VAL SEQRES 21 A 294 GLU GLU GLU GLN GLY ALA LYS LYS HIS ASN MET PRO PHE SEQRES 22 A 294 TRP ARG ILE SER CYS HIS ALA ASP LEU GLU ALA LEU ARG SEQRES 23 A 294 HIS ALA LEU GLU LEU GLU TYR LEU HET 1RI B 601 30 HET 1RI A 601 30 HETNAM 1RI 3-PHENOXY-~{N}-[(~{E})-(5-PYRIMIDIN-2-YLSULFANYLFURAN- HETNAM 2 1RI 2-YL)METHYLIDENEAMINO]BENZAMIDE FORMUL 3 1RI 2(C22 H16 N4 O3 S) HELIX 1 AA1 PHE B 282 GLY B 288 1 7 HELIX 2 AA2 GLY B 288 GLY B 295 1 8 HELIX 3 AA3 ASP B 297 HIS B 319 1 23 HELIX 4 AA4 VAL B 374 LYS B 395 1 22 HELIX 5 AA5 ASN B 397 ILE B 402 1 6 HELIX 6 AA6 ARG B 407 ALA B 419 1 13 HELIX 7 AA7 LEU B 423 SER B 437 1 15 HELIX 8 AA8 GLN B 450 GLY B 462 1 13 HELIX 9 AA9 PRO B 468 GLU B 470 5 3 HELIX 10 AB1 THR B 478 GLY B 492 1 15 HELIX 11 AB2 VAL B 504 LYS B 512 1 9 HELIX 12 AB3 HIS B 523 LEU B 535 1 13 HELIX 13 AB4 PHE A 282 GLY A 288 1 7 HELIX 14 AB5 GLY A 288 GLY A 295 1 8 HELIX 15 AB6 ASP A 297 LEU A 320 1 24 HELIX 16 AB7 VAL A 336 ASP A 340 5 5 HELIX 17 AB8 VAL A 374 LYS A 395 1 22 HELIX 18 AB9 ARG A 407 ALA A 419 1 13 HELIX 19 AC1 LEU A 423 SER A 437 1 15 HELIX 20 AC2 GLN A 450 TYR A 461 1 12 HELIX 21 AC3 PRO A 468 GLU A 470 5 3 HELIX 22 AC4 THR A 478 GLY A 492 1 15 HELIX 23 AC5 VAL A 504 LYS A 512 1 9 HELIX 24 AC6 CYS A 522 LEU A 535 1 14 SHEET 1 AA1 5 ILE B 472 SER B 474 0 SHEET 2 AA1 5 CYS B 441 THR B 447 1 N LEU B 445 O TYR B 473 SHEET 3 AA1 5 ARG B 269 ASP B 274 1 N PHE B 271 O VAL B 442 SHEET 4 AA1 5 VAL B 496 GLY B 501 1 O ILE B 500 N VAL B 272 SHEET 5 AA1 5 PHE B 517 ARG B 519 1 O TRP B 518 N VAL B 499 SHEET 1 AA2 5 ILE A 472 SER A 474 0 SHEET 2 AA2 5 CYS A 441 THR A 447 1 N LEU A 445 O TYR A 473 SHEET 3 AA2 5 ARG A 269 ASP A 274 1 N TRP A 273 O VAL A 446 SHEET 4 AA2 5 VAL A 496 GLY A 501 1 O VAL A 496 N VAL A 270 SHEET 5 AA2 5 PHE A 517 ARG A 519 1 O TRP A 518 N VAL A 499 CISPEP 1 THR B 404 PRO B 405 0 7.63 CISPEP 2 THR A 404 PRO A 405 0 7.04 CRYST1 89.920 89.920 96.850 90.00 90.00 120.00 P 31 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011121 0.006421 0.000000 0.00000 SCALE2 0.000000 0.012841 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010325 0.00000